Introduction
Due to the short half-life of the majority of blood cell lineages, during steady state, millions of different mature blood cells are replenished every second in man [1] . The integrity of this process is strictly dependent on the existence of a rare population of hematopoietic stem cells (HSCs) with extensive self-renewing properties as well as the ability to commit and generate all blood cell lineages to persistently support hematopoiesis throughout the life of an individual [2] .
Natural killer (NK) cells are lymphocytes primarily participating in the innate immunity but also having important roles in regulating the adaptive immune responses. Diverse NK cell functions include an early defense that can directly eliminate infected and transformed cells by immediate cytotoxic activity, but also via cytokine (tumor necrosis factor and interferon-␥ ) and chemokine production, with the latter serving to generate and sustain an inflammatory environment and influence adaptive immunity [3] . Thus, NK cells prime B-and T-cell responses, and cross-talk between NK cells and den dritic cells is required to generate efficient immune response [4] .
After bone marrow transplantation, donor NK cells play a protective role against alloreactive T cells initiating the graft versus host disease [5] , and mismatched NK cells provide the graft versus leukemia effect in acute myeloid leukemia patients. Also, by producing hematopoietic growth factors such as granulocyte/macrophage colonystimulating factor, macrophage colony-stimulating factor and interleukin (IL)-3, NK cells are involved in modulating hematopoiesis [3] . Excitingly, NK cells were recently demonstrated to also have the capacity for memory-like responses, a property previously thought to be limited to adaptive immunity [6] .
A current prevailing model suggests that bone marrow in the adult is the primary site of NK cell development in steady state [7] . However, NK cells have also been shown to arise at the sites that were traditionally thought to be occupied only by the adaptive immune cells [8] , such as the thymus [9] and lymph nodes [10] . NK cells are also found in the gut-associated lymphoid tissues and are specialized in IL-22 production [11, 12] . Further, the subset of NK cells in the uterine mucosa plays an important function during fetal development by regulating the trophoblast invasion and development of the placenta [13] . Characterization and understanding of the functional diversity of NK cell subsets and how these distinct effector cells develop is important to fully realize the potential of NK cell-based therapies [14] .
Lineage commitment is the process by which a multipotent stem or progenitor cell becomes increasingly restricted in its lineage fate choices, to ultimately develop into a fully committed progenitor of a single cell lineage. Decades of extensive research provided the evidence that the lineage commitment of HSCs occurs as a stepwise process; however, the cellular pathways and restriction sites, to generate unipotent progenitors of the lymphoid lineage, remain the subject of debate and investigation [15, 16] .
Turning on lineage-specific gene programs leads to lineage specification, while repression of lineage-inappropriate gene programs and concomitant restriction of alternative lineage differentiation potential drives the lineage commitment [17, 18] . Such transcriptional events are coordinated by networks of transcription factors and their associated chromatin remodeling factors, presumably under the guidance of extrinsic signals from the local environment.
On the road map of NK lineage commitment and development, several questions remain. Are all diverse mature NK cell subsets generated from the same NK lineagerestricted progenitor (NKP)? What is the relationship between NKPs and other lymphoid progenitors? What is the direct predecessor cell upstream of NKP? Where and when do NK cells develop and differentiate? What is the relationship between the thymic and bone marrow NK developmental pathways? From the perspective of these outstanding questions, I have here attempted to review the current knowledge and controversies in the field, with a focus on mouse NK cell development.
NK Cell Development in Adult Mice
From HSCs to Immature NK Cells -The Bone Marrow-Dependent Pathway All the blood cell types are derived from HSCs that reside in bone marrow in the adult individual [15] . HSCs have unique properties of self-renewal required to maintain the blood cell production over the lifetime of the host.
A considerable amount of data supports the hierarchical model of hematopoiesis in which mature blood cells are generated from HSCs in an ordered fashion through a stepwise loss of self-renewal and lineage potentials. This process of HSC differentiation starts with the loss of the self-renewing ability and generation of multipotent progenitors (MPPs), while the developmental stages downstream of MPPs are less defined. The prevailing model of HSC commitment established by the Weissman group predicts that HSCs and MPPs gradually lose their selfrenewing ability and sustain pluripotentiality, whereas downstream progenitors exhibit lineage restriction which occurs in a stepwise manner [15] .
A number of recent improvements in methodology, used for the prospective purification of candidate progenitors, as well as assays evaluating their lineage potential, allow an alternative road map for blood development to be drawn. The classical model of hematopoiesis proposed a first branching point -a strict lineage commitment/restriction into lymphoid and myeloerythroid lineages -which was supported by identification of the common lymphoid (CLPs) [19] and the common myeloid progenitors [20] . The CLPs can only generate lymphoid cells (T, B and NK cells) [19] , while the common myeloid progenitors can produce myeloid and erythroid/megakaryocyte cells [20] . However, identification of lymphoidprimed MPPs (LMPPs) that lack erythroid/megakaryocyte potential but retain both lymphoid and myeloid potential [21] suggested an alternative hematopoietic hierarchy ( fig. 1 ). Based on this finding, a revised model of hematopoiesis proposes the existence of lymphoid-myeloid progenitors as an intermediate stage in T, B, NK cell and myeloid development [21] .
The most immature hematopoietic progenitors in adult mouse bone marrow have a lineage negative (Lin -), stem cell antigen 1 positive (SCA-1 + ), tyrosine kinase receptor CKIT high (KIT high ) phenotype (so-called LSK cells) [22] . The LSK compartment is very heterogeneous and can be further sub-fractionated into different stem and progenitor populations based on multiple additional markers. Self-renewing long-term reconstituting HSCs in adult mice are contained within a small fraction of LSK cells that lack the expression of fms-tyrosine kinase receptor FLT3 [21, 23] , do not express CD34 molecule [24] represents LMPP, that has both lymphoid (B, T, NK cells) and myeloid potentials but has little or no ability to generate the erythroid or megakaryocyte lineages and expresses high levels of transcripts for multiple lymphoid genes [16, 21, 27] . Thus, the LMPP population is the earliest lineage-restricted lymphomyeloid progenitor identified in mouse hematopoiesis [16] .
Downstream of the LSK compartment (HSCs, MPPs and LMPPs), there are several progenitors that posses NK cell linage potential, including the CLPs, defined based on the expression of low levels of SCA-1 and KIT and high levels of IL-7 receptor ␣ chain (IL-7R ␣ ) and FLT3 ( The acquisition of IL-2R ␤ (CD122) that together with IL-15R ␣ and the common ␥ chain is a part of the IL-15 receptor complex, marks the commitment to the NK lineage, and CD122 continues to be expressed through all the NK cell developmental stages [7, 33] . A candidate NKP has been identified in adult mouse bone marrow as lacking the expression of lineage-specific as well as mature NK cell markers and expressing IL-2R ␤ (CD122; [33] ; however, the lineage poten tial of this NKP has not been extensively studied, and its in vivo reconstituting ability was not evaluated. We have recently demonstrated that the Lin -CD122 + NK1.1 -DX5 -cells, in addition to having a robust NK cell potential, sustain the ability to generate T cells in vivo , as well as in vitro at the single cell level, thus representing a bipotent NK/T-cell progenitor [34] . Therefore, the identity of the progenitor restricted to NK cell lineage is yet to be established. The CLPs are negative for CD122 and the hierarchical relation between early lymphoid progenitors as well as the progenitor directly upstream of NKPs remains unclear. The fact that the fraction of NKPs expresses IL-7R ␣ , KIT and FLT3 [33] [34] [35] [36] suggests that they are downstream of CLPs.
The bone marrow is the main site of NK cell development as the ablation of the bone marrow environment is associated with dramatic defects in NK cell compartment and function [37] . Essentially, all the stages of NK cell development take place in the bone marrow, including the generation of NKPs, differentiation and maturation of developing NK cells, NK cell education and the emergence of fully competent functional NK cells [7] . NKPs were also found in the other mouse tissues including the thymus, spleen and lymph nodes [7, 33, 38] , suggesting that NKPs and immature NK cells are not unique to the bone marrow and that other sites can support NK cell differentiation. Alternatively, NKPs and immature NK cells generated in the bone marrow might seed the other tissues through the circulation. In contrast to the early stages of NK cell development, the more terminal steps of NK cell maturation are better understood. Based on the studies from the laboratories of Di Santo [7] and Yokoyama et al. [39] , a model of NK cell development downstream of NKPs has been established in adult mouse bone marrow. In this model, the differentiation of NKPs to immature NK cells involves progressive acquisition of NK cell receptors starting with CD161c (NKRP1C, a family of C-type lectin receptors) recognized by the anti-NK1.1 antibody in C57BL/6 and C57BL/10 mouse strains, a marker that can also be detected on NK T cells and subsets of ␥ ␦ T cells [40, 41] . The natural cytotoxicity receptor NKp46 (NCR1) is restricted to the NK lineage and starts to be expressed on immature NK cells downstream of NKPs [42] . The NKp46 is considered to be the most specific NK cell lineage marker. The differentiation of immature NK cells into functionally mature NK cells involves sequential acquisition of multiple cell surface receptors such as CD94/NKG2A/ C/E and Ly49 (recognizing major histocompatibility complex class I) and DX5/CD49b, with the final maturation being associated with increased expression of CD11b/ Mac-1 and CD43 molecules [7, 43] . Mature NK cells leave the bone marrow and migrate to the periphery and are primarily found in the spleen, blood, lungs and lymph nodes, as well as some of them recirculating through the bone marrow ( fig. 2 ) [44] .
The Thymic NK Cell Developmental Pathway
A distinct population of NK cells that has reduced cytotoxic activity and is highly efficient in secreting cytokines has been recently identified in the thymus of adult mice [9] . In contrast to the conventional bone marrowdependent NK cells, thymic NK (tNK) cells lack the expression of Ly49, Mac-1 and CD43 receptors but express IL-7R ␣ [9] . The cells with the tNK cell phenotype are also present in the lymph nodes, but not in the spleen or bone marrow and do not develop in athymic mice (Foxn1 -/-) [9] . The origin of tNK cells remains controversial, and the developmental relationship between bone marrow and tNK pathways is not known. Although tNK cells depend on the thymic environment, it is not clear whether they are generated from the progenitors that seed the thymus or whether they are derived from the bone marrow NK cells and undergo final maturation in the thymus. In support of the first possibility, previous studies have shown that the early thymic progenitors (ETPs) can generate both T and NK cells in vitro [45] . We have recently shown that tNK cells and bone marrow-dependent NK cells can be generated from both NKPs as well as from ETPs at the single cell level [34] , and their generation is not restricted by Notch signaling. Recent studies using Notch-1-deficient and RBP(CSL)-deficient bone marrow chimeras demonstrated that loss of Notch signaling did not alter the generation of tNK cells, suggesting that tNK cells can develop independently of T-cell progenitors [46] . However, further studies are needed to determine to what degree NKPs and ETPs contribute to generate NK cells in the thymus in vivo.
A distinct population of NKPs has also been identified in the mouse lymph nodes [10] . These progenitors resemble double-negative (DN) thymocytes with LinCD44 + CD25
-(DN1) and Lin -CD44 + CD25 lo (pre-DN2) phenotypes and express very low levels of IL-7R ␣ [10] . However, both IL-7R + and IL-7R -DN progenitors in the lymph nodes have been shown to generate NK cells in vitro [10] . It remains to be determined how much these lymph node NK progenitors contribute to the different NK cell compartments as well as their origin. The lymph node NK progenitors are undetectable in athymic mice, suggesting that they might develop from thymic progenitors migrating and seeding the lymph nodes [9, 10] .
Recent studies identified a population of NK-like lymphoid cells in the intestine that do not express NK1.1 receptor, but are positive for NKp46 and produce IL-22 [11, 12] . These cells were named 'natural cytotoxicity receptor 22' or NK-22 based on the expression of NK cell lineage markers and the ability to produce IL-22 [11, 47] . However, further characterization of intestinal NKp46 + cell subsets suggests that they are different from conventional NK cells and represent distinct innate cell lineage. It has been recently postulated that the innate lymphoid cells include: (1) NK cells, (2) lymphoid tissue inducer cells, and (3) cells that produce ILs: IL-5, IL-13, IL-17 and/or IL-22 [48] . The different subsets of innate lymphoid cells are developmentally related and depend on the expression of transcription factor Id2 and cytokine signaling through the common ␥ chain and IL-2R [47, 48] . Further studies are needed to establish direct progenitors, as well as signals governing their development, to resolve the controversy in the field.
NK Cell Development in the Mouse Embryo
The relationship between fetal and adult NK cell development is poorly understood. Multiple fetal tissues (liver, thymus, spleen) contain hematopoietic progenitors that have the potential to generate NK cells; however, the biological importance of fetal NK cell development is not clear.
The liver is the main site of hematopoiesis during fetal development [49] . The HSCs in the embryo originate within the intra-embryonic sites, i.e. in the aorta-gonadomesonephros region derived from the paraaortic splanchnopleura and in the placenta [49, 50] , as well as in the extra-embryonic site -in the yolk sac [51] . The fetal liver starts to be colonized by hematopoietic progenitors between days E10 and E12, and from day E12 to E15, the number of HSCs increases exponentially [52] . The fetal spleen is colonized by HSCs and hematopoietic progenitors from day E13.5 and is considered to be a transient hematopoietic organ as it becomes an adult immune organ [52] .
Using recombination activating gene 1 (RAG1) expression as a marker for the most primitive lymphoid progenitors, Yokota et al. [53] provided a detailed chart of the emergence and expansion of cells giving rise to the cells of the immune system. The first RAG1-enhanced green fluorescence protein (EGFP)-expressing cells were found in the embryo proper at day E10.5, at day E11 in the fetal liver and at day E12.5 within the thymus [53] . These RAG-1 + EGFP + CD45 + progenitors have the ability to generate B and T cells in vitro; however, their NK cell lineage potential was not investigated. The fetal equivalent of CLP that has been identified in the liver in 14.5-day-old fetus retains, in addition to T, B and NK cell lymphoid potential, significant myeloid potential [54] .
The [59] , as well as in the fetal liver at day E15 as B220 low KIT + CD19 -cells [60] . It remains unclear whether these bipotent NK/T-cell progenitors are directly upstream of NKPs. In most of the studies, the lineage potential of these progenitor cells was only evaluated in vitro; thus, their physiological contribution to NK and other lymphoid lineages in the developing embryo is not known.
Previous studies have shown that the NK1.1 + mature NK cells are detected first in the fetal thymus at day E14, and then at day E16 in the fetal liver as well as in the spleen [61] . Studies in adult mice suggested that commitment to the NK lineage coincides with the upregulation of the surface expression of the IL-2R ␤ CD122 [33] . To determine the time and the sites when different NK cell populations arise during development, we performed detailed flow cytometric analyses of different mouse fetal tissues. Cells negative for mature lineage markers and expressing CD122 (Lin -CD122 + ) arise first in the fetal liver at day E13.5, while the CD3 -NK1.1 + DX5 + NK cells can be first detected in the fetal liver at day E14.5 and in the spleen at day E15.5. Mature NK cells with lytic activity are first found in the fetal liver at day E16.5 and in the spleen at day E17. . It is currently unclear whether the fetal NKPs first expand in the fetal liver and then migrate to the other tissues through the circulation or whether they arise independently in the different embryonic sites. Likewise, it remains to be determined what contribution to the generation of the mature NK cell compartments these differentially located NKPs make.
Conclusion
Recent progress in understanding NK cell biology has identified multiple NK cell populations, each with distinct properties that appear to be generated as the result of distinct developmental programs that are regulated by alternative intrinsic and extrinsic mechanisms. Further studies are needed to understand the relationship between these diverse NK progenitors, their origin as well as their contributions to the mature NK cell compartments. Uncovering how different microenvironments/ tissues support the development of NK cell subsets will help to identify critical extrinsic factors supporting NK cell lymphopoiesis and to understand how they affect de-veloping NK cells. Identifying the cellular NK developmental pathway(s) and its regulatory networks will further drive the therapeutic application of NK cells and establish the molecular basis for diseases that result from altered NK cell development including syndromes manifesting as NK cell deficiencies and NK cell malignancies.
